We are live on ! Find out more
FMI

Foundation Medicine, Inc.
FMI

Delisted

FMI was delisted on the 30th of July, 2018.

103 hedge funds and large institutions have $456M invested in Foundation Medicine, Inc. in 2017 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 37 increasing their positions, 24 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

160% more call options, than puts

Call options by funds: $40.2M | Put options by funds: $15.5M

111% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 9

54% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 24

26% more capital invested

Capital invested by funds: $362M → $456M (+$94.2M)

11% more funds holding

Funds holding: 93103 (+10)

25% less funds holding in top 10

Funds holding in top 10: 43 (-1)

Holders
103
Holders Change
+10
Holders Change %
+10.75%
% of All Funds
2.57%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.07%
New
19
Increased
37
Reduced
24
Closed
9
Calls
$40.2M
Puts
$15.5M
Net Calls
+$24.8M
Net Calls Change
+$23M
Name Holding Trade Value Shares
Change
Change in
Stake
GGHC
1
Gilder Gagnon Howe & Co
New York
$62.9M -$1.05M -28,600 -2%
BlackRock
2
BlackRock
New York
$55.3M +$2.06M +56,383 +4%
Chevy Chase Trust
3
Chevy Chase Trust
Maryland
$41.6M -$1.8M -49,282 -4%
DGI
4
Discovery Group I
Illinois
$33M -$17.4M -475,108 -36%
OC
5
Oppenheimer & Co
New York
$27.2M +$331K +9,050 +1%
AllianceBernstein
6
AllianceBernstein
Tennessee
$27M -$3.98M -108,680 -14%
Vanguard Group
7
Vanguard Group
Pennsylvania
$25.1M +$1.75M +47,843 +8%
Lord, Abbett & Co
8
Lord, Abbett & Co
New Jersey
$23M +$12.6M +343,770 +146%
State Street
9
State Street
Massachusetts
$20.9M +$10.7M +291,815 +124%
CC
10
Casdin Capital
New York
$19.1M
AAMU
11
Amundi Asset Management US
Massachusetts
$14.7M +$1.62M +44,315 +14%
AIM
12
ARK Investment Management
Florida
$10.9M +$601K +16,413 +6%
Baillie Gifford & Co
13
Baillie Gifford & Co
United Kingdom
$9.87M +$2.69M +73,500 +42%
Northern Trust
14
Northern Trust
Illinois
$7.46M +$472K +12,881 +7%
PC
15
Pier Capital
Connecticut
$6.13M +$5.64M +154,101 New
Geode Capital Management
16
Geode Capital Management
Massachusetts
$5.62M +$47.3K +1,291 +0.9%
ACM
17
Adalta Capital Management
New York
$5.23M +$210K +5,725 +5%
Susquehanna International Group
18
Susquehanna International Group
Pennsylvania
$3.68M +$3.39M +92,552 New
BAMCO Inc
19
BAMCO Inc
New York
$3.61M +$110K +3,000 +3%
PIM
20
Platinum Investment Management
Australia
$3.6M -$242K -6,600 -7%
Fidelity Investments
21
Fidelity Investments
Massachusetts
$3.36M -$100K -2,741 -3%
Macquarie Group
22
Macquarie Group
Australia
$3.18M
Bank of New York Mellon
23
Bank of New York Mellon
New York
$2.45M +$30.6K +835 +1%
Charles Schwab
24
Charles Schwab
California
$2.4M +$198K +5,404 +10%
NIM
25
Needham Investment Management
New York
$2.29M

FMI Hedge Fund Activity: Q2 2017 in Review

103 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Foundation Medicine, Inc. (FMI) for Q2 2017, worth a combined $456M — up 26% from $362M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new FMI positions and 9 closed out — a net gain of 10 holders — while 37 added to existing stakes and 24 trimmed.

The largest buyer was Lord, Abbett & Co, adding an estimated $12.6M. The largest seller was Discovery Group I, cutting an estimated $17.4M.

  • 103 institutional investors held Foundation Medicine, Inc. (FMI) as of Q2 2017, up from 93 in Q1 2017.
  • Funds reported $456M of Foundation Medicine, Inc. stock for Q2 2017, up 26% quarter-over-quarter.
  • 19 funds opened new Foundation Medicine, Inc. positions in Q2 2017 and 9 closed out, a net change of +10 holders.
  • The largest Foundation Medicine, Inc. buyer in Q2 2017 was Lord, Abbett & Co, an estimated $12.6M added.
  • The largest Foundation Medicine, Inc. seller in Q2 2017 was Discovery Group I, an estimated $17.4M sold.

Based on aggregated 13F filings for Q2 2017.